Loading...
Antibody–drug conjugates as novel anti-cancer chemotherapeutics
Over the past couple of decades, antibody–drug conjugates (ADCs) have revolutionized the field of cancer chemotherapy. Unlike conventional treatments that damage healthy tissues upon dose escalation, ADCs utilize monoclonal antibodies (mAbs) to specifically bind tumour-associated target antigens and...
Na minha lista:
| Udgivet i: | Biosci Rep |
|---|---|
| Main Authors: | , |
| Format: | Artigo |
| Sprog: | Inglês |
| Udgivet: |
Portland Press Ltd.
2015
|
| Fag: | |
| Online adgang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4613712/ https://ncbi.nlm.nih.gov/pubmed/26182432 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1042/BSR20150089 |
| Tags: |
Tilføj Tag
Ingen Tags, Vær først til at tagge denne postø!
|